By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Chiasma Inc. 

10 Hartom Street, 2nd Floor
P.O. Box 45182
Jerusalem    91450  Israel
Phone: 972-2-571-5885 Fax: 972-2-571-5886


SEARCH JOBS








Company News
Roche (RHHBY) Backs Out Of $600 Million Acromegaly Drug Development Deal With Chiasma Inc. 8/13/2014 5:55:26 AM
Roche (RHHBY) and Chiasma Inc. to Ally on Drug Development for Up to $600 Million 2/19/2013 6:58:50 AM
Chiasma Inc. Closes $38.5 Million Equity Financing 7/23/2012 10:20:16 AM
Chiasma Inc. Release: Data on Investigational Oral Octreolin™ for Acromegaly Demonstrate Growth Hormone Suppression 6/27/2012 9:31:44 AM
Chiasma Inc. to Present at the UBS Global Life Sciences Conference 9/14/2011 10:54:14 AM
Chiasma Inc.'s Octreolin(TM) (Oral Octreotide) Shown to Inhibit Growth Hormone in Healthy Subjects 6/6/2011 11:41:29 AM
Chiasma Inc. to Present at the UBS Global Life Sciences Conference 9/21/2010 8:31:44 AM
Chiasma (Israel) Ltd. Receives Orphan Drug Designation From the FDA for Octreolin(TM) for the Oral Treatment of Acromegaly 6/28/2010 9:01:15 AM
Chiasma Secures $11 Million 1/12/2009 8:54:46 AM
Chiasma Raises $44 Million Series C To Fund Clinical Testing, Advance Technology 11/15/2006 9:42:22 AM
12
//-->